TITLE

Saw palmetto did not differ from placebo for benign prostatic hyperplasia in men

PUB. DATE
July 2006
SOURCE
ACP Journal Club;Jul/Aug2006, Vol. 145 Issue 1, p12
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article presents information on a study which determines how saw palmetto did not vary from placebo for benign prostatic hyperplasia in men. The study is supported by the National Institute of Diabetes and Digestive and Kidney Disease and the National Center for Complementary and Alternative Medicine in the United States. The study findings suggest that in men with moderate-to-severe symptoms, is saw palmetto more effective than placebo for benign prostatic hyperplasia. The study has 90% power to detect a 3-point difference between groups on the American Urological Association Symptom Index score.
ACCESSION #
21692882

 

Related Articles

  • Transition zone index has predictive value in BPH. Binder, Stefanie Petrou // Urology Times;5/1/2005, Vol. 33 Issue 5, p16 

    This article focuses on a study conducted by Claus G. Roehrborn and colleagues, which reports that prostate transition zone index can be a useful measure in predicting changes in symptoms and maximum flow rate, as well as the risk of acute urinary retention and benign prostatic hyperplasia...

  • Don't overlook impact of inflammation on BPH. Schaeffer, Anthony J. // Urology Times;5/1/2005, Vol. 33 Issue 5, p2 

    This article discusses the impact of inflammation on benign prostatic hyperplasia (BPH), and suggests that one should not overlook the impact of inflammation. A research conducted by Claus Roehrborn has shown that prostate inflammation adversely impacts outcomes in men with BPH, an intriguing...

  • An analysis of the costs of alternative treatments for benign prostatic hypertrophy. Vale, J. A.; Bdesha, A. S.; Witherow, R. O'N. // Journal of the Royal Society of Medicine;Nov1995, Vol. 88 Issue 11, p644P 

    The article presents the costs of alternative treatments for benign prostatic hypertrophy. An analysis of the required treatment for benign prostatic hypertrophy in a man's lifetime is estimated and studied. It is concluded that the most effective and mostly used available treatment is...

  • Effect of Mahayavanala Roma Kshara and Dhanyaka Gokshura Ghrita in benign prostatic hyperplasia. Vasava, Yogesh R.; Bhuyan, Chaturbhuja; Rajagopala, Manjusha; Gupta, S. K.; Dudhamal, T. S. // AYU: An International Quarterly Journal of Research in Ayurveda;Jul-Sep2010, Vol. 31 Issue 3, p332 

    Vatastheela is a disease of Mutravahasrotasa, one among the 12 types of Mutraghata disorders elaborated by Sushruta in his seminal work, the Sushruta Samhita. Vatastheela, as described in Ayurveda, closely resembles benign prostatic hyperplasia (BPH) of modern medicine in its signs and symptoms....

  • BPH patients with inflammation show heightened risk of AUR. Binder, Stefanie Petrou // Urology Times;5/1/2005, Vol. 33 Issue 5, p1 

    This article reports that according to a first-time investigation into the impact of acute and/or chronic inflammation on men with benign prostatic hyperplasia (BPH), prostate inflammation significantly raises the risk of clinical progression in men with lower urinary tract symptoms and BPH. The...

  • Effect of silodosin on specific urinary symptoms associated with benign prostatic hyperplasia: analysis of international prostate symptom scores in 2 phase III clinical studies. Gittelman, Marc C.; Marks, Leonard S.; Hill, Lawrence A.; Volinn, Weining; Hoel, Gary // Research & Reports in Urology;2011, Issue 3, p1 

    Purpose: Pooled results from 2 randomized, placebo-controlled, US phase III studies (NCT00224107, NCT00224120) showed that silodosin, a uroselective α-blocker, significantly improved International Prostate Symptom Scores (IPSS) in men with symptomatic benign prostatic hyperplasia (BPH). This...

  • Combination Therapy for the Pharmacological Management of Benign Prostatic Hyperplasia: Rationale and Treatment Options. Sandhu, Jaspreet S.; Vaughan Jr, E. Darracott // Drugs & Aging;2005, Vol. 22 Issue 11, p901 

    The management of symptomatic benign prostatic hyperplasia (BPH) continues to evolve, with new techniques and forms of medical management being introduced and traditional surgical techniques being used less frequently. Medical management of BPH has evolved from nonspecific α-adrenoceptor...

  • TERAZOSIN VS FINASTERIDE FOR BPH. Zacks, Michael // Journal of Family Practice;Dec1996, Vol. 43 Issue 6, p533 

    The article presents a Comparison of terazosin, finasteride and combination therapy in the treatment of benign prostatic hypertrophy (BPH). Men aged 45 to 80 with symptomatic benign prostatic hyperplasia who were seen in Veterans Affairs outpatient clinics were enrolled. This was a four-armed,...

  • HOW REAL IS THE PLACEBO EFFECT? Guterl, Fred // Newsweek (Atlantic Edition);06/18/2001 (Atlantic Edition), Vol. 137 Issue 25, p49 

    Comments on the placebo effect and the use of the mind-body connection as a bona fide medical treatment. Discussion of a study appearing in the May 2001 issue of 'Science,' which suggests that the power of placebo is a myth; Popularity of alternative medicine and treatment; Criticism of the...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics